To amend the Public Health Service Act to deem any insulin that is determined by the Secretary to be biosimilar to the reference product to be interchangeable with the reference product, and for other purposes.
About This Bill
Introduced
Latest Action · September 16, 2020
Sponsor introductory remarks on measure. (CR H4487)